Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism

Table 1 Demographic and clinical characteristics of patients with hypersplenism (mean ± SD)

	Group A(n = 27)	Group B(n = 34)	P value
Age (yr)	48.48 ± 8.87	47.945 ± 7.32	0.445
Female/male	11/15	14/20	0.930
Child-Pugh classification, n (%)			0.441
A	19 (70.4)	23 (676)
B	6 (22.2)	9 (26.5)
C	2 (7.4)	2 (5.8)
Virus, n (%)			0.463
B	22 (81.5)	25 (73.5 )
C	5 (19.5)	9 (26.5)
WBC counts × 109	1.50 ± 0.32	1.54 ± 0.30	0.453
PLT counts × 109	40.33 ± 6.16	39.74 ± 4.63	0.574
Splenic volume (cm3)	769.93 ± 61.40	745.73 ± 50.09	0.201

WBC: White blood cell; PLT: Platelet.

Table 2 Post-procedural computed tomography results, clinical outcomes, and complications (mean ± SD)

	Group A (n = 27)	Group B (n = 34)	P value
Technical success, n (%)	27 (100)	34 (100)	0.999
Hospital stay (d)	8.52 ± 1.91	15.88 ± 6.36	< 0.001
Complications, n (%)			0.007
Minor complications			0.005
Post-embolization syndrome	21 (77.8)	34 (100)
Major complications	0 (0)	7 (20.6)	0.014
Splenic abscess	0	2
Pleural effusion	0	3
Ascites	0	2
CT follow-up (mo)	36.44 ± 12.67	36.00 ± 11.82	0.926
Clinical follow-up (mo)	40.63 ± 12.60	40.14 ± 11.58	0.965
WBC count > 4 × 109/L at 2-year follow-up, n (%)	27 (100)	21 (62)	< 0.001

WBC: White blood cell; CT: Computed tomography.